These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26285577)

  • 41. Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion.
    Yasuda S; Kondo M; Kachi S; Ito Y; Terui T; Ueno S; Terasaki H
    Retina; 2011 Jun; 31(6):1075-82. PubMed ID: 21478810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial.
    Kreutzer TC; Wolf A; Dirisamer M; Strauss RW; Foerster P; Feltgen N; Pielen A; Hattenbach LO; Kampik A; Priglinger SG
    Ophthalmologica; 2015; 233(1):8-17. PubMed ID: 25502833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.
    Fan C; Wang Y; Ji Q; Zhao B; Xie J
    Curr Eye Res; 2014 Sep; 39(9):938-43. PubMed ID: 24635755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion:results after 12 months and multiple regression analysis.
    Kondo M; Kondo N; Ito Y; Kachi S; Kikuchi M; Yasuma TR; Ota I; Kensaku M; Terasaki H
    Retina; 2009 Oct; 29(9):1242-8. PubMed ID: 19672216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion.
    Singer M; Tan CS; Bell D; Sadda SR
    Retina; 2014 Sep; 34(9):1736-42. PubMed ID: 24732695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TIME COURSE OF CHANGES IN METAMORPHOPSIA FOLLOWING INTRAVITREAL RANIBIZUMAB INJECTION FOR BRANCH RETINAL VEIN OCCLUSION.
    Sugiura Y; Okamoto F; Morikawa S; Okamoto Y; Hiraoka T; Oshika T
    Retina; 2018 Aug; 38(8):1581-1587. PubMed ID: 28614133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time to clinically significant visual acuity gains after ranibizumab treatment for retinal vein occlusion: BRAVO and CRUISE trials.
    Thach AB; Yau L; Hoang C; Tuomi L
    Ophthalmology; 2014 May; 121(5):1059-66. PubMed ID: 24424249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2009; 29(10):1396-403. PubMed ID: 19898177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategy for the management of macular edema in retinal vein occlusion: the European VitreoRetinal Society macular edema study.
    Adelman RA; Parnes AJ; Bopp S; Saad Othman I; Ducournau D
    Biomed Res Int; 2015; 2015():870987. PubMed ID: 25705695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K; Hayashi H
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy and safety of intravitreal dexamethasone implants for macular oedema secondary to retinal vein occlusion: 3-year experience.
    Higham A; Jacob S; Cox M; Baker C; Al-Husainy S; Sivaraj R; Gibson JM
    Acta Ophthalmol; 2016 Nov; 94(7):e674-e675. PubMed ID: 27010078
    [No Abstract]   [Full Text] [Related]  

  • 53. Peripheral Laser for Recalcitrant Macular Edema Owing to Retinal Vein Occlusion: The WAVE Trial.
    Wykoff CC; Ou WC; Wang R; Brown DM; Cone C; Zamora D; Le RT; Sagong M; Wang K; Sadda SR;
    Ophthalmology; 2017 Jun; 124(6):919-921. PubMed ID: 28318636
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.
    Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Babu RB; Narayana KM
    Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
    Russo V; Barone A; Conte E; Prascina F; Stella A; Noci ND
    Retina; 2009 Apr; 29(4):511-5. PubMed ID: 19174717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.
    Campochiaro PA; Heier JS; Feiner L; Gray S; Saroj N; Rundle AC; Murahashi WY; Rubio RG;
    Ophthalmology; 2010 Jun; 117(6):1102-1112.e1. PubMed ID: 20398941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitrectomy for macular edema combined with retinal vein occlusion.
    Tachi N; Hashimoto Y; Ogino N
    Doc Ophthalmol; 1999; 97(3-4):465-9. PubMed ID: 10896365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology.
    Yeh S; Kim SJ; Ho AC; Schoenberger SD; Bakri SJ; Ehlers JP; Thorne JE
    Ophthalmology; 2015 Apr; 122(4):769-78. PubMed ID: 25576994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion.
    Yasuda S; Kachi S; Ueno S; Piao CH; Terasaki H
    Acta Ophthalmol; 2015 Sep; 93(6):e465-8. PubMed ID: 25597703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Retinal vein occlusion: anti-VEGF treatments].
    Nghiem-Buffet S; Cohen SY
    J Fr Ophtalmol; 2009 Nov; 32(9):679-86. PubMed ID: 19879018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.